These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 13993294)

  • 1. [Results and significance of mass gynecologic examinations during therapeutic treatment].
    STUMMER E
    Dtsch Med J; 1962 Dec; 13():747-9. PubMed ID: 13993294
    [No Abstract]   [Full Text] [Related]  

  • 2. [Screening. Gynecological cases inan internal medical clinic].
    JOHNSSON JE
    Sven Lakartidn; 1963 May; 60():1344-53. PubMed ID: 14041965
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of systematic examinations in detection of gynecologic cancer, our experiences in the conducting of examinations].
    Softić D; Maglajlić M; Popović A; Stevanović-Softić A; Skobić M; Volić M
    Med Arh; 1967; 21(5):41-5. PubMed ID: 5189319
    [No Abstract]   [Full Text] [Related]  

  • 4. [Organization of prophylactic gynecologic exams with mass cytological screening of women].
    Buval'tseva NA; Kvashenko BK
    Pediatr Akus Ginekol; 1978; (3):35-6. PubMed ID: 673514
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for gynecologic cancer.
    Campion MJ; Reid R
    Obstet Gynecol Clin North Am; 1990 Dec; 17(4):695-727. PubMed ID: 2092238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on the use of CA-125 in gynecologic mass screening].
    Nakatani K; Hoshiai H; Wada Y; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Jan; 39(1):157-60. PubMed ID: 3469285
    [No Abstract]   [Full Text] [Related]  

  • 7. [Screening for malignant gynecologic tumors].
    Ebeling K
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):715-9. PubMed ID: 8237067
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of gynecologic preventive examinations--perspectives].
    Hochuli E; Rageth C
    Geburtshilfe Frauenheilkd; 1990 Jun; 50(6):483-7. PubMed ID: 2376309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [On the economic aspects of prebiopsy technics in gynecology].
    Sedlák M; Dohnal V
    Cesk Zdrav; 1967 Jan; 15(1):23-8. PubMed ID: 6044359
    [No Abstract]   [Full Text] [Related]  

  • 10. [Organization of preventive examinations in gynecology].
    Lanĕ V; Antos J; Kanka J; Kronus R; Magát A; Rosol M
    Cesk Gynekol; 1972 Oct; 37(8):609-13. PubMed ID: 4638459
    [No Abstract]   [Full Text] [Related]  

  • 11. Gynecologic cancers: Part. II--risk assessment and screening.
    Lee CO
    Clin J Oncol Nurs; 2000; 4(2):73-7. PubMed ID: 11107379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for improving gynecologic cytology screening.
    Renshaw AA
    Cancer; 2009 Jun; 117(3):151-3. PubMed ID: 19618478
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent surgical approaches to gynecologic oncology.
    Duffy MS
    Nurs Clin North Am; 2001 Sep; 36(3):603-15, xii. PubMed ID: 11532673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytological centers. Contribution on the planning of centers for the detection and therapy of precancerous conditions at regional (medical school) type 3 gynecologic-obstetrical departments from the construction technological viewpoint].
    Vácha K; Príbrský J; Bednárová F
    Cesk Gynekol; 1970 Sep; 35(7):428-9. PubMed ID: 5473541
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimum screening interventions for gynecologic malignancies.
    Lea JS; Miller DS
    Tex Med; 2001 Feb; 97(2):49-55. PubMed ID: 11233059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Age and incidence of gynecologic diseases in the light of prophylactic mass examinations].
    Pieczurowski T; Penar S; Maszkiewicz W
    Pol Tyg Lek; 1972 Oct; 27(40):1562-5. PubMed ID: 4639086
    [No Abstract]   [Full Text] [Related]  

  • 17. [Screening in gynecologic oncology].
    Ebeling K
    Zentralbl Gynakol; 1983; 105(19):1225-38. PubMed ID: 6316692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice.
    Santillan A; Govan L; Zahurak ML; Diaz-Montes TP; Giuntoli RL; Bristow RE
    Gynecol Oncol; 2008 Jun; 109(3):388-93. PubMed ID: 18405946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for gynecologic cancer in an unselected healthy population in the frame work of health examinations of the Caisse Primaire Centrale d'Assurance Maladie de la Région Parisienne].
    Micholet J; Blond A
    Rev Fr Gynecol Obstet; 1971; 66(11):639-42. PubMed ID: 5148536
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for gynecologic cancer.
    Pretorius G
    Surg Oncol Clin N Am; 1998 Apr; 7(2):263-9. PubMed ID: 9537975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.